Same Day Ambulatory Appendectomy (SAMBA)
SAMBA
1 other identifier
interventional
1,400
2 countries
33
Brief Summary
The potential benefit of outpatient care for this common digestive emergency is considerable, both for the patients themselves and for the public health system:
- 1.Optimization of the care pathway, reducing the length of stay in hospital (a major issue in the context of the COVID-19 (coronavirus disease) pandemic) liberating patient beds and staff, and reducing the risk of nosocomial exposure.
- 2.Improved patient satisfaction compared to waiting for hours in the emergency department due to lack of hospital beds.
- 3.Non-inferiority of care in an outpatient unit in terms of quality and safety in day hospitalization.
- 4.Significant decrease in the overall cost of this pathology as a result of a reduction in the hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
33 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2023
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedStudy Start
First participant enrolled
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 17, 2028
March 31, 2026
March 1, 2025
4.5 years
January 9, 2023
March 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To demonstrate that outpatient care, compared with conventional care, in selected patients with acute uncomplicated appendicitis operated by laparoscopy, is non-inferior in terms of overall morbi-mortality on the 30th postoperative day.
Morbi-mortality will be assessed by classifying post-operative complications according to Clavien-Dindo classification. It will be compared between both groups ("ambulatory pathway" versus "conventional hospitalization" CONV) on the 30th postoperative day. The Clavien-Dindo classification was originally published in 2004 in the Annals of Surgery for elective general surgery. Later, it has been objectively validated for all surgical specialties. This classification ranks complications from 0 (no complication) to 5 (death). Complications that potentially lead to long-lasting disability after discharge (e.g.: paralysis of a vocal cord after thyroid surgery) are highlighted in the present classification by a suffix ("d" for disability). This suffix indicates that a long-term follow-up is required to comprehensively evaluate the outcome and related long-term quality of life.
30 days post surgery
Secondary Outcomes (16)
To compare between both groups, at post-operative day 30, the delay from diagnosis to appendectomy
30 days post surgery
To compare between both groups, at post-operative day 30, the real cumulated length of hospitalization
30 days post surgery
To compare between both groups, at post-operative day 30, the rehospitalization rate
30 days post surgery
To compare between both groups, the mild morbidity (Clavien-Dindo I-II) during 30 days post surgery
up to the 30th day post surgery
To compare between both groups, the severe morbidity (Clavien-Dindo III, IV, V) during 30 days post surgery
up to the 30th day post surgery
- +11 more secondary outcomes
Study Arms (2)
Ambulatory pathway
EXPERIMENTALConventional hospitalisation
ACTIVE COMPARATORInterventions
Appendectomy will be performed in digestive surgery department. Patient will be discharge from the hospital the day after surgery: he will spend a night under observation
Appendectomy will be performed in outpatient surgery unit. Patient will be discharge from the hospital the same day as surgery
Eligibility Criteria
You may qualify if:
- Patients aged 15-74 years
- BMI ≤ 35 kg/m2
- Uncomplicated acute appendicitis confirmed by imaging (ultrasound and/or CT and/or MRI)
- Temperature ≤ 38,1°C and \> 35,5°C
- Appendix diameter \> 6mm and ≤ 15mm
- Without effusion or with only localized peri-appendicular effusion
- Infiltration of peri-appendicular fat without abscess or plastron
- No sign of perforation
- Leukocytes ≤ 18,000G/L AND
- CRP (C reactive protein) ≤ 60mg/L
- If pain, calmed by level 3 analgesic at maximum
- Ambulatory criteria
- Availability of monitoring by a relative during the 12 hours after discharge from the hospital
- Residence located less than 20 minutes by car from a health center (hospital or clinic)
- Access to a telephone mobile or fixed in case of problems
- +3 more criteria
You may not qualify if:
- Criteria that exclude ambulatory care such as an ASA score (Physical status score) \> 2, severe or uncontrolled comorbidities, severe pulmonary disease including obstructive sleep apnea, anticoagulation or antiplatelet drug or contraindication to ambulatory surgery such as intubation difficulties
- Presence of active cancer, a malignant hemopathy, drug addiction, coagulopathy, immunosuppressive treatment
- Non-acute or interval appendectomy, i.e. after antibiotic treatment of a complicated appendicitis of the plastron or drainage of an appendicular abscess;
- History of pelvic surgery
- Vulnerable people: pregnant or breast-feeding women (patients will undergo a pregnancy test: plasmatic β-hCG (human chorionic gonadotropin) or urinary test), adult under guardianship or deprived of freedom. Pregnant women are considered to have a full stomach, with risk of inhalation at anesthetic induction and represent a contraindication to ambulatory surgery. In addition, the need to perform abdominal surgery on a pregnant woman requires obstetric monitoring that is difficult to reconcile with management in an outpatient surgery unit (need for obstetric ultrasound or monitoring).
- Suspicion of a tumor of the appendix : Mucocele and pseudomyxoma, Carcinoid tumor, Adenocarcinoma of the appendix, Another type of tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (33)
Hôpitaux Pédiatriques de Nice CHU - Lenval
Nice, Alpes Maritimes, 06200, France
CHU de Nice
Nice, Alpes-Maritimes, 06000, France
CHU de Bordeaux
Bordeaux, Aquitaine, 33076, France
CH de Troyes
Troyes, Aube, 10000, France
CHU Grenoble Alpes
La Tronche, Auvergne-Rhône-Alpes, 38700, France
Hôpital Edouard HERRIOT
Lyon, Auvergne-Rhône-Alpes, 69003, France
CHU de Saint-Etienne - Hôpital Nord
Saint-Priest-en-Jarez, Auvergne-Rhône-Alpes, 42270, France
CH de Voiron
Voiron, Auvergne-Rhône-Alpes, 38500, France
APHM Hôpital Nord
Marseille, Bouches-du-Rhône, 13326, France
CHU Minjo
Besançon, Bourgogne-Franche-Comté, 25000, France
CHU de Rennes
Rennes, Brittany Region, 35000, France
Hôpital Robert Debré - CHU de Reims
Reims, Grand Est, 51092, France
Hôpital Beaujon (APHP)
Clichy, Hauts de Seine, 92110, France
CHU Amiens-Picardie
Amiens, Hauts-de-France, 80054, France
Clinique de Saint-Omer
Blendecques, Hauts-de-France, 62575, France
HIA Percy
Clamart, Hauts-de-Seine, 92140, France
CHU de Tours
Tours, Indre Et Loire, 37044, France
CHU de Reims
Reims, Marne, 51100, France
CH de Dax
Dax, Nouvelle-Aquitaine, 40107, France
CH de Mont de Marsan
Mont-de-Marsan, Nouvelle-Aquitaine, 40000, France
Hôpital Cochin APHP
Paris, Paris, 75014, France
CHU d'Angers
Angers, Pays de la Loire Region, 49933, France
Hôpital d'Instruction des armées Laveran
Marseille, Provence-Alpes-Côte d'Azur Region, 13384, France
Hôpital d'Instruction des armées Sainte Anne - BCRM Toulon
Toulon, Provence-Alpes-Côte d'Azur Region, 83800, France
Clinique du Val d'Ouest
Écully, Rhones-Alpes, 69130, France
Hôpital Avicenne
Bobigny, Île-de-France Region, 93000, France
Hôpital Louis-Mourier
Colombes, Île-de-France Region, 92700, France
APHP Pitié Salpetrière
Paris, Île-de-France Region, 75013, France
APHP Lariboisière
Paris, Île-de-France Region, 75475, France
Hia Begin
Saint-Mandé, Île-de-France Region, 94160, France
Clinique de l'Estrée
Stains, Île-de-France Region, 93240, France
CHU de La Réunion
Saint-Denis, La Réunion, 97400, Reunion
CHU de La Réunion
Saint-Pierre, La Réunion, 97448, Reunion
Related Publications (1)
Arvieux C, Tidadini F, Barbois S, Fontas E, Carles M, Gridel V, Orban JC, Quesada JL, Foote A, Cruzel C, Anthony S, Bulsei J, Hivelin C, Massalou D. SAME day amBulatory c (SAMBA): a multicenter, prospective, randomized clinical trial protocol. Trials. 2024 Sep 9;25(1):601. doi: 10.1186/s13063-024-08336-x.
PMID: 39252106DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2023
First Posted
January 20, 2023
Study Start
July 17, 2023
Primary Completion (Estimated)
January 17, 2028
Study Completion (Estimated)
January 17, 2028
Last Updated
March 31, 2026
Record last verified: 2025-03